Laboratorios Lemery

Laboratorios Lemery is a prominent Mexican pharmaceutical company specializing in the development, manufacturing, and commercialization of generic medicines, with a primary focus on oncology and critical care. Founded in 1980 and headquartered in Mexico City, the company established itself as a leader in the Latin American high-value generics market before its acquisition by Sicor, which was subsequently acquired by Teva Pharmaceutical Industries. Today, Lemery operates as a vital component of Teva's Latin American operations, maintaining sophisticated manufacturing facilities that produce a wide array of injectable and oral treatments. Its portfolio is heavily weighted toward hospital-grade medications, particularly chemotherapy agents and supportive care therapies. The company is recognized for its commitment to providing affordable, high-quality alternatives to complex off-patent pharmaceuticals.